Pharmacy Report Archives - Page 13 of 153 - Becker's Hospital Review

Retail pharmacy growth pressures hospitals | Novo launches Wegovy subscription | CVS eyes net store growth | GLP-1s show addiction treatment potential | FDA OKs 1st pediatric immune gene therapy

Plus: Republicans eye healthcare cuts to fund Iran war March 31, 2026 1. Retail pharmacy growth raises stakes for hospitals Full story 2. Novo offers Wegovy subscription program Full story 3. Up to 9 systems for 1 therapy start. Fix…

6 notes on the pharmacy tech workforce | Drugs most at risk amid Iran conflict | Top PBMs by 2025 share | 4 ways GLP-1s are changing care | FDA OKs 1st weekly basal insulin

Iran drug supply risks, pharmacy tech workforce updates and GLP-1 notes top today’s news March 30, 2026 1. 6 things to know about the pharmacy technician workforce Full story 2. The medications most at risk amid Iran war-driven supply threats…

Lawmakers push $35 insulin cap | Hunter syndrome gets 1st drug in decades | Fla. restores HIV drug access | House panel warns on China's drug supply role | CMS' GLP-1 pilot: 6 key notes

$35 insulin bill, new Hunter syndrome therapy and China drug supply warning top today’s news March 26, 2026 1. Bipartisan bill would cap insulin at $35 per month Full story 2. FDA OKs 1st Hunter syndrome therapy in decades Full…

Covenant Health taps CPO | After GLP-1s, what's next? | HHS invests $8.3M to boost hospital drug supply | FTC nears settlement with CVS Caremark | ADHD drug shortage tied to supply failures

GLP-1 rebound questions, FDA cancer drug warning and CVS settlement lead today’s news March 25, 2026 1. Covenant Health names chief pharmacy officer Full story 2. What happens after patients stop GLP-1s? Full story 3. For Dartmouth Health, alignment between…

5 pharmacy market trends | Medicaid drug spend up 46% as Rx volume stalls | Gene therapy co. reports stockout | Pfizer's Lyme vaccine heads to FDA | Lilly's next-gen GLP-1 boosts weight loss, A1C

Pharmacy market trends, gene therapy shortage and GLP-1 push top today’s news March 24, 2026 1. Inside the 2026 pharmacy market: 5 key trends Full story 2. 5 things to know about Medicaid drug spending: KFF Full story 3. Chief…

10 future blockbuster drugs to watch | Mount Sinai names CPO | TrumpRx's 57 drugs | 15 hospital med safety best practices | ASHP taps former Cleveland Clinic exec as CEO

Future blockbuster drugs, Mount Sinai CPO and TrumpRx expansion top today’s news March 23, 2026 1. 10 drugs poised to be global best-sellers in 2030 Full story 2. Mount Sinai names chief pharmacy officer Full story 3. Procurement blind spots…

8 new drugs in shortage | TrumpRx tops 50+ drugs with Mark Cuban backing | FDA clears higher-dose Wegovy, recalls 89K children's ibuprofen bottles | ASHP fills 3,872 residency spots

TrumpRx expansion, new drug shortages and Wegovy approval top today’s news March 19, 2026 1. 8 drugs in shortage Full story 2. Mark Cuban supports TrumpRx as platform scales to 50+ drugs Full story 3. Find case studies in pharmacies…

TrumpRx prices miss global low-cost mark | 6 drugmakers to know | HHS plans $200M cancer vaccine initiative | IRA linked to stronger med adherence | GLP-1s tied to lower SUD risk

TrumpRx price gap, HHS cancer vaccine push and new psoriasis pill top today’s news March 18, 2026 1. TrumpRx prices fail to match global low-cost promise Full story 2. 6 pharmaceutical companies to know | 2026 Full story 3. Procurement…

Cone CPO eyes systemwide pharmacy growth | 15 largest US pharmacies | FDA rejects eye drug candidate | 3 GLP-1 updates | Baptist pharmacy leader joins Prisma

Plus: HCA’s highest-earning executives. March 17, 2026 1. Not just 'cost cutting': How Cone Health is repositioning pharmacy Full story 2. Top 15 pharmacies by 2025 prescription revenue Full story 3. Hear 90+ pharmacy executives discuss cost, workforce & clinical…

US-Iran conflict threatens generic drug supply | Drug affordability worries hit new high | Lilly flags compounded GLP-1 risks | Clinicians divided on unproven autism drug | CMS advances 3rd Medicare drug round

Iran conflict risks generics, Medicare drug talks and medication affordability fears top today’s new March 16, 2026 1. US-Iran conflict threatens generic drug supply Full story 2. Drug affordability worries highest since 2018: KFF poll Full story 3. This is…